Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | ASLAN003 |
| Synonyms | |
| Therapy Description |
ASLAN003 inhibits dihydroorotate dehydrogenase (DHODH), which may induce differentiation and inhibit proliferation of leukemia cells (PMID: 33054053). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| ASLAN003 | ASLAN 003|ASLAN-003 | DHODH Inhibitor 6 | ASLAN003 inhibits dihydroorotate dehydrogenase (DHODH), which may induce differentiation and inhibit proliferation of leukemia cells (PMID: 33054053). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT03451084 | Phase II | ASLAN003 | A Dose Optimisation Study of ASLAN003 in Acute Myeloid Leukemia | Completed | USA | AUS | 1 |